Page last updated: 2024-11-05

trimethoprim and Di Guglielmo Disease

trimethoprim has been researched along with Di Guglielmo Disease in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research Excerpts

ExcerptRelevanceReference
"Cultures of Friend erythroleukemia cells were subjected to the antibiotics trimethoprim (T) and sulfamethoxazole (S) at levels equal to or below the usual therapeutic range."1.26The effect of trimethoprim/sulfamethoxazole on Friend erythroleukemia cells. ( Campbell, CL; Hillman, RS; Rabinovitch, PS; Steinberg, SE, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinberg, SE1
Campbell, CL1
Rabinovitch, PS1
Hillman, RS1

Other Studies

1 other study available for trimethoprim and Di Guglielmo Disease

ArticleYear
The effect of trimethoprim/sulfamethoxazole on Friend erythroleukemia cells.
    Blood, 1980, Volume: 55, Issue:3

    Topics: Cell Transformation, Neoplastic; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Erythrocyte

1980